Nexium (Esomeprazole)

Esomeprazole, the active ingredient in Nexium, is a proton pump inhibitor presented as an oral dosage form for oral use. It reduces gastric acid production and is prescribed for conditions such as gastro‑oesophageal reflux disease, erosive esophagitis, peptic ulcer disease, Helicobacter pylori eradication regimens, and Zollinger‑Ellison syndrome.

GNH USA supplies Nexium as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nexium is a proton pump inhibitor used to manage acid‑related gastrointestinal disorders.

- Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of esophageal irritation. - Erosive esophagitis: accelerates mucosal healing and prevents disease progression. - Peptic ulcer disease: supports ulcer healing and reduces recurrence risk. - Helicobacter pylori eradication regimens: enhances the effectiveness of antibiotic combinations. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with gastrin‑producing tumors.

Adverse reactions may occur with any medication and should be monitored.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually transient. - Nausea: may occur after dosing. - Abdominal pain: mild discomfort. - Flatulence: excess gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis risk. - Severe allergic reaction (anaphylaxis): rash, swelling, breathing difficulty. - Stevens‑Johnson syndrome: skin blistering and detachment. - Elevated liver enzymes: hepatic function alteration. - Hypomagnesemia: low magnesium levels with prolonged use. - Bone fracture risk: decreased calcium absorption with long‑term therapy.

Before initiating therapy, consider the following safety measures.

- Assess renal function: adjust use in severe impairment. - Monitor magnesium levels: especially during prolonged treatment. - Use cautiously in hepatic disease: liver metabolism may be affected. - Avoid in known hypersensitivity to esomeprazole or other PPIs. - Evaluate fracture risk: long‑term use may affect bone density. - Store at ambient temperature: keep in the original pack, protect from moisture.

Esomeprazole can alter the plasma concentrations of several co‑administered drugs.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet activation. - Atazanavir: decreased antiviral absorption. - HIV protease inhibitors (e.g., ritonavir): altered exposure.

Moderate Interactions (Monitor Closely): - Digoxin: increased serum levels. - Phenytoin: reduced phenytoin concentrations. - Calcium carbonate: decreased esomeprazole absorption.